-
Signature
-
/s/ Lindsay L. Katz pursuant to Confirming Statement
-
Issuer symbol
-
THG
-
Transactions as of
-
07 May 2025
-
Net transactions value
-
-$886,368
-
Form type
-
4
-
Filing time
-
08 May 2025, 16:17:44 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Salvatore Bryan J |
Executive Vice President |
C/O THE HANOVER INSURANCE GROUP, INC., 440 LINCOLN STREET, WORCESTER |
/s/ Lindsay L. Katz pursuant to Confirming Statement |
08 May 2025 |
0001709075 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
THG |
Common Stock |
Options Exercise |
$867,237 |
+10,526 |
+41% |
$82.39 |
36,390 |
07 May 2025 |
Direct |
F1 |
| transaction |
THG |
Common Stock |
Sale |
$826,447 |
-4,975 |
-14% |
$166.12 |
31,415 |
07 May 2025 |
Direct |
F1, F2 |
| transaction |
THG |
Common Stock |
Sale |
$908,033 |
-5,437 |
-17% |
$167.01 |
25,978 |
07 May 2025 |
Direct |
F1, F3 |
| transaction |
THG |
Common Stock |
Sale |
$19,125 |
-114 |
-0.44% |
$167.76 |
25,864 |
07 May 2025 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
THG |
Common Stock Option (right to buy) |
Options Exercise |
$0 |
-10,526 |
-100% |
$0.000000 |
0 |
07 May 2025 |
Common Stock |
10,526 |
$82.39 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: